Associate Professor
Pediatric Hematology & Oncology
Dr. Michael R. Verneris, MD
|
|
Give Review
Dr. Michael R. Verneris practices Pediatric Hematology & Oncology. He attended Warren Alpert Medical School of Brown University. Dr. Michael R. Verneris is a published doctor as well. He has 102 publications published. The latest was: Metabolic Syndrome After Hematopoietic Cell Transplantation: At the Intersection of Treatment Toxicity and Immune Dysfunction.
Publications
- Impact of Allele-Level HLA Mismatch on Outcomes in Recipients of Double Umbilical Cord Blood Transplantation.
- CD56(dim)CD57(+)NKG2C(+) NK cell expansion is associated with reduced Leukemia relapse after reduced intensity HCT.
- IL-15 Trispecific Killer Engagers (TriKEs) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing In Vivo Expansion, and Enhanced Function.
- Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile and clinical effect.
- Is It Better to Be Rich or Relaxed? Sociobiology Meets Bone Marrow Transplant.
- Circulating Angiogenic Factors associated with Response and Survival in Patients with Acute Graft-versus-Host Disease: Results from Blood and Marrow Transplant Clinica...
- Phase I Study of a Bispecific Ligand-Directed Toxin Targeting CD22 and CD19 (DT2219) for Refractory B-cell Malignancies.
- Multi-institutional Feasibility Study of a Fast Patient Localization Method in Total Marrow Irradiation With Helical Tomotherapy: A Global Health Initiative by the Int...
- The effects of 1,25-dihydroxyvitamin d3 on in vitro human NK cell development from hematopoietic stem cells.
- An exploratory analysis of mitochondrial haplotypes and allogeneic hematopoietic cell transplantation (HCT) outcomes.
- Notch Signaling at Later Stages of NK Cell Development Enhances KIR Expression and Functional Maturation.
- Impact of long term cryopreservation on single umbilical cord blood transplant outcomes.
- Cytotoxic T-lymphocyte antigen-4 single nucleotide polymorphisms are not associated with outcomes after unrelated donor transplantation: a center for international blo...
- Clinical outcomes of AML patients relapsing after matched-related donor and umbilical cord blood transplantation.
- A Therapeutic Trial of Decitabine and Vorinostat in Combination with Chemotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL).
- Clearance of Acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein.
- A clofarabine-based bridging regimen in patients with relapsed ALL and persistent minimal residual disease (MRD).
- Clinical utility of natural killer cells in Cancer therapy and transplantation.
- CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells from MDS patients against primary MDS and MDSC CD33+ targets.
- The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT).
- Prevention of Graft-versus-Host Disease by Adoptive T Regulatory Therapy Is Associated with Active Repression of Peripheral Blood Toll-Like Receptor 5 mRNA Expression.
- Peripheral dose heterogeneity due to the thread effect in total marrow irradiation with helical tomotherapy.
- Similar outcomes between adolescent/young adults and children with AML following allogeneic hematopoietic cell transplantation.
- How do we define complete remission for Acute myeloid leukemia in the current era? Results of an international survey.
- Targeting Natural Killer cells to Acute Myeloid Leukemia in vitro with a CD16x33 bispecific killer cell engager (BiKE) and ADAM17 inhibition.
- Heterodimeric Bispecific Single-Chain Variable-Fragment Antibodies Against EpCAM and CD16 Induce Effective Antibody-Dependent Cellular Cytotoxicity Against Human Carci...
- Allogeneic Hematopoietic Cell Transplantation in First Remission Abrogates Poor Outcomes Associated with High-Risk Pediatric Acute Myeloid Leukemia.
- Early hematopoietic stem cell transplant is associated with favorable outcomes in children with MDS.
- Pericardial effusion after pediatric hematopoietic cell transplant.
- Lineage relationships of human IL-22 producing CD56+ ROR?t+ innate lymphoid cells and conventional NK cells.
- Survival differences between adolescents/young adults and children with B precursor Acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation.
- A randomized trial of one versus two doses of influenza vaccine after allogeneic transplantation.
- The epic race to immune reconstitution.
- Visualization of tumor growth and response to NK-T cell based immunotherapy using bioluminescence.
- Thyroid carcinoma after successful treatment of osteosarcoma: a report of three patients.
- Pediatric HIV infection and chronic myelogenous Leukemia.
- Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production.
- Survivin expression correlates with apoptosis resistance after lymphocyte activation and is found preferentially in memory T cells.
- High-dose therapy and autologous hematopoietic cell transplantation in children with primary refractory and relapsed Hodgkin's disease: atopy predicts idiopathic diffu...
- Resistance of ex vivo expanded CD3+CD56+ T cells to Fas-mediated apoptosis.
- Engineering hematopoietic grafts: purified allogeneic hematopoietic stem cells plus expanded CD8+ NK-T cells in the treatment of lymphoma.
- Hodgkin disease-derived cell lines expressing ubiquitous mitochondrial creatine kinase show growth inhibition by cyclocreatine treatment independent of apoptosis.
- Advancing animal models of neoplasia through in vivo bioluminescence imaging.
- Autologous stem cell transplantation for high-risk Ewing''s sarcoma and other pediatric solid tumors.
- CD56(dim)CD16(+) NK cells downregulate CD16 following target cell induced activation of matrix metalloproteinases.
- Maternal hemoglobin concentration during pregnancy and risk of infant leukaemia: a children''s oncology group study.
- Helical tomotherapy targeting total bone marrow - first clinical experience at the University of Minnesota.
- Allo-hematopoietic cell transplantation for Ph chromosome-positive ALL: impact of imatinib on relapse and survival.
- Multimodality image guided total marrow irradiation and verification of the dose delivered to the Lung, PTV, and thoracic bone in a patient: a case study.
- High-unbound mycophenolic acid concentrations in an infant on peritoneal dialysis following hematopoietic cell transplant.
- Imatinib use either pre- or post-allogeneic hematopoietic cell transplantation (allo-HCT) does not increase cardiac toxicity in chronic myelogenous Leukemia patients.
- Lower Leukemia relapse in pediatric patients with pulmonary cytolytic thrombi following allogeneic transplant.
- Allogeneic hematopoietic cell transplantation outcomes for children with B-precursor Acute lymphoblastic leukemia and early or late BM relapse.
- Early lymphocyte recovery and outcomes after umbilical cord blood transplantation (UCBT) for hematologic Malignancies.
- Acquisition, preparation, and functional assessment of human NK cells for adoptive immunotherapy.
- Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood.
- Killing the killer: natural killer cells to treat Ewing's sarcoma.
- Polysaccharide-K augments docetaxel-induced tumor suppression and antitumor immune response in an immunocompetent murine model of human prostate Cancer.
- Successful Remission Rates and Survival after Lymphodepleting Chemotherapy for Relapsed Hematologic Malignancies Post Allogeneic Hematopoietic Cell Transplant.
- Peritransplant palifermin use and lymphocyte recovery after T-cell replete, matched related allogeneic hematopoietic cell transplantation.
- NK-cell education after allogeneic transplantation: dissociation between recovery of cytokine producing and cytotoxic functions.
- Allogeneic hematopoietic stem cell transplantation overcomes the adverse prognostic impact of CD20 expression in Acute lymphoblastic leukemia.
- Development of IL-22-producing NK lineage cells from umbilical cord blood hematopoietic stem cells in the absence of Secondary lymphoid tissue.
- Natural killer-cell differentiation by myeloid progenitors.
- Reduced-intensity conditioning followed by related allografts in hematologic Malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin ly...
- The TREC to less CMV after UCBT.
- Novel approaches to prevent Leukemia relapse following allogeneic hematopoietic cell transplantation.
- Reduced-intensity conditioning regimens for allogeneic transplantation in children with Acute lymphoblastic leukemia.
- Natural killer cell killing of Acute myelogenous leukemia and Acute lymphoblastic leukemia blasts by killer cell immunoglobulin-like receptor-negative natural killer c...
- UCB and atmospheric noise.
- Natural killer cell consolidation for Acute myelogenous leukemia: a cell therapy ready for prime time?
- Limited role of MHC class I chain-related gene A (MICA) typing in assessing graft-versus-host disease risk after fully human leukocyte antigen-matched unrelated donor ...
- The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cells.
- Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation.
- Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive Acute lymphoblastic leukemia (ALL).
- Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-Leukemia effect in recipients of 2 units.
- Costs of pediatric allogeneic hematopoietic-cell transplantation.
- Hematopoietic cell transplantation for children with Acute lymphoblastic leukemia in second complete remission: similar outcomes in recipients of unrelated marrow and ...
- Myeloablative hematopoietic cell transplantation for Acute lymphoblastic leukemia: analysis of graft sources and long-term outcome.
- Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity.
- Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity.
- Prolonged survival in adults with Acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantation.
- Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more Acute graft-versus-host disease than DLI alone.
- The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations.
- O-glycoside biomarker of apolipoprotein C3: responsiveness to obesity, bariatric surgery, and therapy with metformin, to chronic or severe liver disease and to mortali...
- Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors.
- Umbilical cord blood T cells express multiple natural cytotoxicity receptors after IL-15 stimulation, but only NKp30 is functional.
- Use of natural killer cells as immunotherapy for leukaemia.
- Allogeneic hematopoietic cell transplantation in children with relapsed Acute lymphoblastic leukemia isolated to the central nervous system.
- Immunotherapy for pediatric Cancer.
- Recent developments in cell-based immune therapy for neuroblastoma.
- Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT.
- iTRAQ is a useful method to screen for membrane-bound proteins differentially expressed in human natural killer cell types.
- Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging.
- Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells.
- Studying multiple protein profiles over time to assess biomarker validity.
- Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells.
- Plasma protein profiling: unique and stable features of individuals.
- Low levels of Her2/neu expressed by Ewing's family tumor cell lines can redirect cytokine-induced killer cells.
- Pulmonary cytolytic thrombi after allogeneic hematopoietic cell transplantation: a further histologic description.
- Metabolic Syndrome After Hematopoietic Cell Transplantation: At the Intersection of Treatment Toxicity and Immune Dysfunction.
Schools
The Warren Alpert Medical School Of Brown University
Chldns National Med Center
Lucille Salter Packard Chldns Hospital
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anemia
- Lung Cancer
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Education
-
Stanford University -
George Washington University -
Warren Alpert Medical School of Brown University
Hospital
-
University of Minnesota Medical Center, Fairview
Helpful Reviews
Similar Doctors
|
|
Dr. Lucie M. Turcotte, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Margaret L. MacMillan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yoav H. Messinger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julie Chu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruce C. Bostrom, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruce R. Blazar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Margaret A. Kurth, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Troy C. Lund, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jawhar Rawwas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan F. Sencer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joanna L. Perkins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul J. Orchard, MD
This Doctor is OpenDoctor Recommended.
|